SEARCH

SEARCH BY CITATION

References

  • 1
    Kawasaki T, Kosaki F, Okawa S et al. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974; 54: 2716.
  • 2
    Lacroix J, Lapointe N, Weber M et al. Prospective study of 64 cases of Kawasaki's disease. Arch Fr Pediatr 1985; 42: 7716.
  • 3
    Lee BW, Tay JS, Yip WC et al. Kawasaki syndrome in Chinese children. Ann Trop Paediatr 1989; 9: 14751.
  • 4
    Salcedo JR, Greenberg L, Kapur S. Renal histology of mucocutaneous lymph node syndrome (Kawasaki disease). Clin Nephrol 1988; 29: 4751.
  • 5
    Dhillon R, Clarkson P, Donald AE et al. Endothelial dysfunction late after Kawasaki disease. Circulation 1996; 94: 21036.
  • 6
    Hashimoto Y, Yoshinoya S, Aikawa T et al. Enhanced endothelial cell proliferation in acute Kawasaki disease (muo-cutaneous lymph node syndrome). Pediatr Res 1986; 20: 9436.
  • 7
    Leung DY, Cortan RS, Kurt-Jones E et al. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 1989; 2: 1298302.
  • 8
    Nash MC, Shah V, Dillon MJ. Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease. Clin Exp Immunol 1995; 101: 137.
  • 9
    Takeshita S, Dobashi H, Nakatani K et al. Circulating soluble selectins in Kawasaki disease. Clin Exp Immunol 1997; 108: 44650.
  • 10
    Wong M, Silverman ED, Fish EN. Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1 beta expression in Kawasaki disease. J Rheumatol 1997; 24: 117985.
  • 11
    Schiller B, Elinder G. Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: relationship to cardiac lesions and intravenous globulin treatment. Acta Paediatr 1999; 88: 8448.
  • 12
    Yasukawa K, Terai M, Shulman ST et al. Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. Circulation 2002; 105: 7669.
  • 13
    Hirose S, Hamashima Y. Morphological observations on the vasculitis in the mucocutaneous lymph node syndrome. A skin biopsy study of 27 patients. Eur J Pediatr 1978; 129: 1727.
  • 14
    Liu AM, Ghazizadeh M, Onouchi Z, Asano G. Ultrastructural characteristics of myocardial and coronary microvascular lesions in Kawasaki disease. Microvasc Res 1999; 58: 1027.
  • 15
    Xu C, Poirier B, Van Huyen JP et al. Modulation of endothelial cell function by normal polyspecific human intravenous immunoglobulins: a possible mechanism of action in vascular diseases. Am J Pathol 1998; 153: 125766.
  • 16
    Fatica NS, Ichida F, Engle MA, Lesser ML. Rug shampoo and Kawasaki disease. Pediatrics 1989; 84: 2314.
  • 17
    Akiyama T, Yashiro K. Probable role of Streptococcus pyogenes in Kawasaki disease. Eur J Pediatr 1993; 152: 8292.
  • 18
    Cohen-Tervaert JW, Popa ER, Bos NA. The role of superantigens in vasculitits. Curr Opin Rheumatol 1999; 11: 2433.
  • 19
    Terai M, Miwa K, Williams T et al. The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J Infect Dis 1995; 172: 55861.
  • 20
    Lloyd AJ, Walker C, Wilkinso M. Kawasaki disease: is it caused by an infectious agent? Br J Biomed Sci 2001; 58: 1228.
  • 21
    Tsujimoto H, Takeshita S, Nakatani K et al. Delayed apoptosis of circulating neutrophils in Kawasaki disease. Clin Exp Immunol 2001; 126: 35564.
  • 22
    Kim HY, Lee HG, Kim DS. Apoptosis of peripheral blood mononuclear cells in Kawasaki disease. J Rheumatol 2000; 27: 8016.
  • 23
    Rowley AH, Shulman ST, Mask CA et al. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney and coronary artery in acute Kawasaki disease. J Infect Dis 2000; 182: 118391.
  • 24
    Falcini F, Trapani S, Turhini S et al. Immunologic findings in Kawasaki disease. An evaluation in a cohort of Italian children. Clin Exp Rheumatol 1997; 15: 6859.
  • 25
    Kaneko K, Savage CO, Pottinger BE et al. Antiendothelial cell antibodies can be cytotoxic to endothelial cells without cytokine pre-­stimulation and correlate with ELISA antibody measurement in Kawasaki disease. Clin Exp Immunol 1994; 98: 2649.
  • 26
    Guzman J, Fung M, Petty RE. Diagnostic value of anti-neutrophil cytoplasmic and anti-endothelial cell antibodies in early Kawasaki disease. J Pediatr 1994; 124: 91720.
  • 27
    Fujieda M, Oishi N, Kurashige T. Antibodies to endothelial cells in Kawasaki disease lyse endothelial cells without cytokine pretreatment. Clin Exp Immunol 1997; 107: 1206.
  • 28
    Ferraro G, Meroni PL, Tincani A et al. Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis. Clin Exp Immunol 1990; 79: 4753.
  • 29
    Frampton G, Jayne DR, Perry GJ et al. Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol 1990; 82: 22732.
  • 30
    Chan TM, Frampton G, Jayne DR et al. Clinical significance of anti-endothelial cell antibodies in systemic vasculitis: a longitudinal study comparing anti-endothelial cell antibodies and anti-neutrophil cytoplasm antibodies. Am J Kidney Dis 1993; 22: 38792.
  • 31
    Leung DY, Geha RS, Newburger JW et al. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med 1986; 164: 195872.
  • 32
    Leung DY, Collins T, Lapierre LA et al. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated with gamma interferon. J Clin Invest 1986; 77: 35.
  • 33
    Nash MC, Shah V, Reader JA, Dillon MJ. Anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies are not increased in Kawasaki disease. Br J Rheumatol 1995; 34: 8827.
  • 34
    Rose NR. The use of autoantibodies. In: PetersJB, ShoenfeldY, eds. Autoantibodies. Netherlands: Elsevier Science B.V., 1996: xxviixxix.
  • 35
    Krause I, Blank M, Shoenfeld Y. The induction of experimental vascular diseases by immunization with pathogenic autoantibodies. Clin Exp Rheumatol 2000; 18: 25761.
  • 36
    Tincani A, Balestrieri G, Allegri F et al. Induction of experimental SLE in naïve mice by immunization with human polyclonal anti-DNA antibody carrying the 16/6 idiotype. Clin Exp Rheumatol 1993; 11: 12934.
  • 37
    Dang H, Ogawa N, Takei M et al. Induction of lupus-associated autoantibodies by immunization with native and recombinant Ig polypeptides expressing a cross-reactive idiotype 4B4. J Immunol 1993; 151: 72607.
  • 38
    Rombach E, Stetler DA, Brown JC. Rabbits produce SLE-like anti-RNA polymerase I and anti-DNA autoantibodies in response to immunization with either human or murine SLE anti-DNA antibodies. Autoimmunity 1992; 13: 291302.
  • 39
    Shoenfeld Y. Idiotypic induction of autoimmunity: a new aspect of the idiotypic network. FASEB J 1994; 8: 1296301.
  • 40
    Damianovich M, Gilburd B, George J et al. Pathogenic role of anti-endothelial cell antibodies in vasculitis. An idiotypic experimental model. J Immunol 1996; 156: 494651.
  • 41
    Bakimer R, Fishman P, Blank M et al. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anti-cardiolipin antibody (H-3). J Clin Invest 1992; 89: 155863.
  • 42
    Tomer Y, Gilburd B, Blank M et al. Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenic role in experimental vasculitis. Arthritis Rheum 1995; 38: 137581.
  • 43
    Anonymous. Diagnostic guidelines for Kawasaki disease. American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease. Am J Dis Child 1990; 144: 12189.
  • 44
    Rosenbaum J, Pottinger BE, Woo P et al. Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol 1988; 72: 4506.
  • 45
    Praprotnik S, Blank M, Levy M et al. Antiendothelial cell antibodies (AECA) from patients with Thrombotic Thrombocytopenic purpura specifically activate small vessel endothelial cells. Int Immunol 2001; 13: 20310.
  • 46
    Blank M, Krause I, Goldkorn T et al. Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels. Arthritis Rheum 1999; 42: 142132.
  • 47
    Renaudineau Y, Grunebaum E, Krause I et al. Anti-endothelial cell antibodies (AECA) in Systemic Sclerosis- Increased sensitivity using different endothelial cell substrates and association with other autoantibodies. Autoimmunity 2001; 33: 1719.
  • 48
    Rafii S, Shapiro F, Rimarachin J et al. Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion. Blood 1994; 4: 109.
  • 49
    Revelen R, Bordron A, Dueymes M et al. False positivity in a cyto-ELISA for anti-endothelial cell antibodies caused by heterophile antibodies to bovine serum proteins. Clin Chem 2000; 46: 2738.
  • 50
    Levy Y, Gilburd B, George J et al. Characterization of murine monoclonal anti-endothelial cell antibodies (AECA) produced by idiotypic manipulation with human AECA. Int Immunol 1998; 10: 8618.
  • 51
    Blank M, Shoenfeld Y, Cabilly S et al. Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proc Natl Acad Sci USA 1999; 96: 51648.
  • 52
    Yazici ZA, Raschi E, Patel A et al. Human monoclonal anti-­endothelial cell IgG-derived from a systemic lupus erythematosus patient binds and activates human endothelium in vitro. Int Immunol 2001; 13: 34957.
  • 53
    Furukawa S, Imai K, Matsubara T et al. Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease. Arthritis Rheum 1992; 35: 6727.
  • 54
    Lehman TJ, Warren R, Gietl D et al. Variable expression of Lactobacillus casei cell wall-induced coronary arteritis: an animal model of Kawasaki's disease in selected inbred mouse strains. Clin Immunol Immunopathol 1988; 48: 10818.
  • 55
    Carvalho D, Savage COS, Isenberg D, Pearson JD. IgG anti-­endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine mannor. Arthritis Rheumat 1999; 42: 63140.
  • 56
    Lin CY, Lin CC, Hwang B, Chiang B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr 1992; 121: 9246.
  • 57
    Ishiguro A, Ishikita T, Shimbo T et al. Elevation of serum thrombopoietin precedes thrombocytosis in Kawasaki disease. Thromb Haemost 1998; 79: 1096100.
  • 58
    Gupta M, Noel Gj Schaefer M et al. Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease. J Clin Immunol 2001; 21: 1939.
  • 59
    Kim DS, Lee KY. Serum soluble E-selectin levels in Kawasaki disease. Scand J Rheumatol 1994; 23: 2836.
  • 60
    Ohta K, Seno A, Shintani N et al. Increased levels of urinary ­interleukin-6 in Kawasaki disease. Eur J Pediatr 1993; 152: 6479.
  • 61
    Rostoker G, Rymer JC, Bagnard G et al. Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schonlein purpura nephritis, and a potential target of immunoglobulin therapy? Clin Exp Immunol 1998; 114: 46876.
  • 62
    Bonany PJ, Bilkis MD, Gallo G et al. Acute renal failure in typical Kawasaki disease. Pediatr Nephrol 2002; 17: 32931.
  • 63
    Chen A, Ding SL, Sheu LF et al. Experimental IgA nephropathy. Enhanced deposition of glomerular IgA immune complex in proteinuric states. Laboratory Invest 1994; 70: 63947.
  • 64
    Hogendoorn PC, Van Dorst EB, Van Der Burg SH et al. Antigen size influences the type of glomerular pathology in chronic serum sickness. Nephrol Dial Transplant 1993; 8: 70310.
  • 65
    Peeters AJ, Van Den Wall Bake AW, Daha MR, Breeveld FC. Inflammatory bowel disease and ankylosing spondylitis associated with cutaneous vasculitis, glomerulonephritis, and circulating IgA immune complexes. Ann Rheum Dis 1990; 49: 63840.
  • 66
    Praprotnik S, Blank M, Meroni PL et al. Classification of anti-­endothelial cell antibodies to antibodies against micro and macrovascular endothelial cell: the pathogenic and diagnostic implications. Arthritis Rheum 2001; 44: 148494.
  • 67
    Del Papa N, Conforti G, Gambini D et al. Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopath 1994; 70: 2116.
  • 68
    Frampton G, Moriya S, Pearson JD et al. Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein P0 as an endothelial cell autoantigen. Rheumatology 2000; 39: 111420.
  • 69
    Yazici ZA, Behrendt N, Cooper D et al. The identification of endothelial cell autoantigens. J Autoimmunity 2000; 15: 419.
  • 70
    Amano S, Hazama F, Hamashima Y. Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes. Jpn Circ J 1979; 43: 63343.
  • 71
    Chantepie A, Mauran P, Lusson JR et al. Cardiovascular complications of Kawasaki syndrome: results of a French multi-center study. Arch Pediatr 2001; 8: 7139.
  • 72
    Lang BA, Silverman ED, Laxer RM, Lau AS. Spontaneous tumor necrosis factor production in Kawasaki disease. J Pediatr 1989; 115: 93943.